Volume 4, Issue 4 (12-2020)                   EBHPME 2020, 4(4): 209-211 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kargar S, Peyvand M, Hajizadeh F. The Novel COVID-19 Infections in Iran: Management and Challenges. EBHPME. 2020; 4 (4) :209-211
URL: http://jebhpme.ssu.ac.ir/article-1-278-en.html
Student Research Committee, Zahedan University of Medical Sciences, Zahedan, Iran
Abstract:   (3920 Views)
The novel coronavirus (COVID-19) was first identified in Wuhan, China, in December 2019 among a cluster of patients that presented with an unidentified form of viral pneumonia with a shared history of visiting the Huanan seafood market. The pathogen has been identified as a novel enveloped RNA Betacoronavirus that has currently been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and has a phylogenetic similarity to SARS-CoV. The World Health Organization (WHO) declared coronavirus disease 2019 (Covid-19), caused by SARS-COV2, is a public health emergency of international concern which is a threat to all countries including Iran.
 
Full-Text [PDF 832 kb]   (3412 Downloads) |   |   Full-Text (HTML)  (1533 Views)  
Type of Study: Letter to Editor | Subject: Healt care Management
Received: 2020/05/17 | Accepted: 2020/12/20 | Published: 2020/12/20

References
1. 1.Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020; 382: 1708-20. doi: 10. 1056/ NEJMoa2002032. [DOI:10.1056/NEJMoa2002032]
2. Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ. Mapping the incidence of the COVID-19 hotspot in Iran-Implications for Travellers. Travel Medicine and Infectious Disease. 2020; 34: 101630. [DOI:10.1016/j.tmaid.2020.101630]
3. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International Journal of Antimicrobial Agents. 2020:105924. [DOI:10.1016/j.ijantimicag.2020.105924]
4. World Health Organization. Coronavirus disease (COVID-2019) situation report-137. 5 June 2020. Available from URL: https:// www. who. int/ emergencies/ diseases/novel-coronavirus-2019/situation-reports. Last access: June 8, 2020.
5. Doshmangir L, Mahbub Ahari A, Qolipour K, Azami-Aghdash S, Kalankesh L, Doshmangir P, et al. East Asia's Strategies for Effective Response to COVID-19: Lessons Learned for Iran. Management Strategies in Health System. 2020; 4(4): 370-3. [DOI:10.18502/mshsj.v4i4.2542]
6. Hashemi-Shahri SM, Khammarnia M, Ansari-Moghaddam A, Setoodehzadeh F, Okati-Aliabad H, Peyvand M. Sources of news as a necessity for improving community health literacy about COVID-19. Medical Journal of the Islamic Republic of Iran (MJIRI). 2020; 34(1): 453-5.
7. Javanian M, Masrour-roudsari J, Bayani M, Ebrahimpour S. Coronavirus disease 2019 (COVID-19): What we need to know (In Press). Caspian Journal of Internal Medicine. 2020; 11(2): 18.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2021 CC BY-NC 4.0 | Evidence Based Health Policy, Management and Economics

Designed & Developed by : Yektaweb